Seizure
41
6
7
26
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.3%
3 terminated out of 41 trials
89.7%
+3.2% vs benchmark
7%
3 trials in Phase 3/4
19%
5 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (41)
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
An Observational Study of the NeuroBell EEG Monitor
Epileptiform Potential of Fully Immersive Virtual Reality
Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
AI-Based Mobile Intervention on Medication Non-Adherence and Transition
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
Pro-Epileptic Effects of IV Ketamine
Efficacy of Low Glycemic Index Diet Versus Classic Ketogenic Diet in Pediatric Epilepsy Treatment
Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures
Procedural Motor Memory in Long COVID-19
Assessment of Pre Hospital Rescue Intervention for Seizure in Pediatric Patients
Seizure Prophylaxis in Aneurysm Repair
Effect of VR-ESMEPP on Parents' Seizure Management
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
Study of Predictors of Response to Anti Epilepsy in Epilepsy
EEG in In-hospital Patients With Seizure or Altered Mental State